145 related articles for article (PubMed ID: 22669332)
1. Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial.
Signori C; DuBrock C; Richie JP; Prokopczyk B; Demers LM; Hamilton C; Hartman TJ; Liao J; El-Bayoumy K; Manni A
Eur J Clin Nutr; 2012 Aug; 66(8):878-84. PubMed ID: 22669332
[TBL] [Abstract][Full Text] [Related]
2. Influence of Obesity on Breast Density Reduction by Omega-3 Fatty Acids: Evidence from a Randomized Clinical Trial.
Sandhu N; Schetter SE; Liao J; Hartman TJ; Richie JP; McGinley J; Thompson HJ; Prokopczyk B; DuBrock C; Signori C; Hamilton C; Calcagnotto A; Trushin N; Aliaga C; Demers LM; El-Bayoumy K; Manni A
Cancer Prev Res (Phila); 2016 Apr; 9(4):275-82. PubMed ID: 26714774
[TBL] [Abstract][Full Text] [Related]
3. Stearoyl-CoA desaturase-1, a novel target of omega-3 fatty acids for reducing breast cancer risk in obese postmenopausal women.
Manni A; Richie JP; Schetter SE; Calcagnotto A; Trushin N; Aliaga C; El-Bayoumy K
Eur J Clin Nutr; 2017 Jun; 71(6):762-765. PubMed ID: 28145413
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 Fatty Acids Responsive Proteins and Reduction in Breast Density in Obese Postmenopausal Women.
Sun YW; Xu H; Benitez G; Chen KM; Stanley A; Stanley B; Zhu J; Thompson H; Manni A; El-Bayoumy K
J Proteome Res; 2019 Sep; 18(9):3461-3469. PubMed ID: 31369706
[TBL] [Abstract][Full Text] [Related]
5. Effects of raloxifene administration on serum levels of insulin-like growth factor-1 and insulin-like growth factor-binding protein 3 levels: A systematic review and meta-analysis of randomized controlled trials.
Sun Y; Xiong Y; Meng YL; Santos HO; Athayde FL; de Souza IGO; Yang L
Growth Horm IGF Res; 2021; 60-61():101421. PubMed ID: 34384975
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women.
Lasco A; Gaudio A; Morini E; Morabito N; Nicita-Mauro C; Catalano A; Denuzzo G; Sansotta C; Xourafa A; Macrì I; Frisina N
Menopause; 2006; 13(5):787-92. PubMed ID: 16912660
[TBL] [Abstract][Full Text] [Related]
7. Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer.
Torrisi R; Baglietto L; Johansson H; Veronesi G; Bonanni B; Guerrieri-Gonzaga A; Ballardini B; Decensi A
Br J Cancer; 2001 Dec; 85(12):1838-41. PubMed ID: 11747323
[TBL] [Abstract][Full Text] [Related]
8. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
Hernández E; Valera R; Alonzo E; Bajares-Lilue M; Carlini R; Capriles F; Martinis R; Bellorin-Font E; Weisinger JR
Kidney Int; 2003 Jun; 63(6):2269-74. PubMed ID: 12753317
[TBL] [Abstract][Full Text] [Related]
9. Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.
Duschek EJ; de Valk-de Roo GW; Gooren LJ; Netelenbos C
Fertil Steril; 2004 Aug; 82(2):384-90. PubMed ID: 15302288
[TBL] [Abstract][Full Text] [Related]
10. Daily Intake of Milk Enriched with n-3 Fatty Acids, Oleic Acid, and Calcium Improves Metabolic and Bone Biomarkers in Postmenopausal Women.
Fonolla-Joya J; Reyes-García R; García-Martín A; López-Huertas E; Muñoz-Torres M
J Am Coll Nutr; 2016 Aug; 35(6):529-536. PubMed ID: 27463412
[TBL] [Abstract][Full Text] [Related]
11. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
[TBL] [Abstract][Full Text] [Related]
12. Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study.
de Valk-de Roo GW; Stehouwer CD; Meijer P; Mijatovic V; Kluft C; Kenemans P; Cohen F; Watts S; Netelenbos C
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2993-3000. PubMed ID: 10591680
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.
Fabian CJ; Kimler BF; Phillips TA; Nydegger JL; Kreutzjans AL; Carlson SE; Hidaka BH; Metheny T; Zalles CM; Mills GB; Powers KR; Sullivan DK; Petroff BK; Hensing WL; Fridley BL; Hursting SD
Cancer Prev Res (Phila); 2015 Oct; 8(10):922-31. PubMed ID: 26276744
[TBL] [Abstract][Full Text] [Related]
14. Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer Prevention.
Manni A; El-Bayoumy K; Skibinski CG; Thompson HJ; Santucci-Pereira J; Bidinotto LT; Russo J
Biomed Res Int; 2015; 2015():638645. PubMed ID: 26339626
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women.
Gibney J; Johannsson G; Leung KC; Ho KK
J Clin Endocrinol Metab; 2005 Jul; 90(7):3897-903. PubMed ID: 15855258
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
Kastelein JJ; Maki KC; Susekov A; Ezhov M; Nordestgaard BG; Machielse BN; Kling D; Davidson MH
J Clin Lipidol; 2014; 8(1):94-106. PubMed ID: 24528690
[TBL] [Abstract][Full Text] [Related]
17. Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo.
Fabian CJ; Befort CA; Phillips TA; Nydegger JL; Kreutzjans AL; Powers KR; Metheny T; Klemp JR; Carlson SE; Sullivan DK; Zalles CM; Giles ED; Hursting SD; Hu J; Kimler BF
Cancer Prev Res (Phila); 2021 Sep; 14(9):893-904. PubMed ID: 34244155
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene lowers IGF-I levels in acromegalic women.
Attanasio R; Barausse M; Cozzi R
Eur J Endocrinol; 2003 Apr; 148(4):443-8. PubMed ID: 12656665
[TBL] [Abstract][Full Text] [Related]
19. Pilot study on omega-3 fatty acids in type I diabetes mellitus.
Landgraf-Leurs MM; Drummer C; Fröschl H; Steinhuber R; Von Schacky C; Landgraf R
Diabetes; 1990 Mar; 39(3):369-75. PubMed ID: 2137803
[TBL] [Abstract][Full Text] [Related]
20. Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women.
De Leo V; la Marca A; Morgante G; Lanzetta D; Setacci C; Petraglia F
Am J Obstet Gynecol; 2001 Feb; 184(3):350-3. PubMed ID: 11228485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
